MassBank MassBank Search Contents Download

MassBank Record: KO004249

Uridine; LC-ESI-QQ; MS2; CE:40 V; [M+H]+

Mass Spectrum
Chemical Structure
Generated by the Chemistry Development Kit (http://github.com/cdk)

ACCESSION: KO004249
RECORD_TITLE: Uridine; LC-ESI-QQ; MS2; CE:40 V; [M+H]+
DATE: 2016.01.19 (Created 2007.07.07, modified 2011.05.10)
AUTHORS: Kakazu Y, Horai H, Institute for Advanced Biosciences, Keio Univ.
LICENSE: CC BY-NC-SA
COMMENT: KEIO_ID U006

CH$NAME: Uridine
CH$COMPOUND_CLASS: N/A
CH$FORMULA: C9H12N2O6
CH$EXACT_MASS: 244.06954
CH$SMILES: OC[C@@H](O1)[C@@H](O)[C@@H](O)[C@@H]1N(C=2)C(=O)NC(=O)C2
CH$IUPAC: InChI=1S/C9H12N2O6/c12-3-4-6(14)7(15)8(17-4)11-2-1-5(13)10-9(11)16/h1-2,4,6-8,12,14-15H,3H2,(H,10,13,16)/t4-,6-,7-,8-/m1/s1
CH$LINK: CAS 58-96-8
CH$LINK: CHEBI 16704
CH$LINK: KEGG C00299
CH$LINK: NIKKAJI J4.593D
CH$LINK: PUBCHEM SID:3593
CH$LINK: INCHIKEY DRTQHJPVMGBUCF-XVFCMESISA-N
CH$LINK: COMPTOX DTXSID40891555

AC$INSTRUMENT: API3000, Applied Biosystems
AC$INSTRUMENT_TYPE: LC-ESI-QQ
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 40 V

MS$FOCUSED_ION: PRECURSOR_M/Z 245
MS$FOCUSED_ION: PRECURSOR_TYPE [M+H]+

PK$SPLASH: splash10-03di-9700000000-1ddefb0b972a63b62682
PK$NUM_PEAK: 29
PK$PEAK: m/z int. rel.int.
  43.000 59406.0 37
  43.800 29703.0 19
  55.400 99010.0 62
  57.000 103960.5 65
  58.300 19802.0 12
  61.100 34653.5 22
  69.200 74257.5 46
  70.000 371287.5 231
  71.000 94059.5 59
  73.100 39604.0 25
  74.000 207921.0 130
  77.900 14851.5 9
  81.000 143564.5 89
  85.500 24752.5 15
  90.600 34653.5 22
  91.200 153465.5 96
  92.100 262376.5 163
  92.400 49505.0 31
  94.200 54455.5 34
  95.200 69307.0 43
  96.400 301980.5 188
  98.000 34653.5 22
  104.800 14851.5 9
  106.600 24752.5 15
  108.400 39604.0 25
  113.200 1603962.0 999
  119.000 143564.5 89
  119.400 19802.0 12
  160.500 14851.5 9
//

Imprint Feedback
system version 2.1.8
Copyright © 2006 MassBank Project; 2011 NORMAN Association; 2021 MassBank Consortium
Responsible: Dr. Tobias Schulze